SPDR S&P Biotech
(AMEX: XBI)
+1.35
+1.24%
| Symbol | Value ($) |
|---|---|
| Previous Close | 109.02 |
| Open | 107.64 |
| Day's High | 110.62 |
| Day's Low | 105.72 |
| Volume | 342,490 |
| Bid | 109.51 |
| Bid Size | 400 |
| Ask | 112.54 |
| Ask Size | 400 |
| 52-Wk High | 112.69 |
| 52-Wk Low | 77.00 |
| Beta | 1.02 |
| YTD NAV Return | +23.89 |
| YTD Market Return | +24.07 |
| Inception Date | 1/31/2006 |
| Shares Outstanding | 8.90 Mil |
- Last trade 5/23/2013 4:00 PM ET
| NA |
|---|
| The investment seeks to provide investment results that, before fees and expenses, correspond to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. The fund employs a replication strategy in seeking to track the performance of the S&P Biotechnology Select Industry Index. It generally invests substantially all, but at least 80%, of total assets in the securities comprising the index. The fund may invest in equity securities that are not included in the index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. It is non-diversified. |
| Symbol | Value ($) |
|---|---|
| 1 Month | 2.30% |
| 3 Months | 13.99% |
| 1 Year | 34.61% |
| 3 Years* | 26.89% |
| 5 Years* | 13.94% |
- * Annualized returns
- Data through 4/29/2013 8:00 PM ET
-
InvestorPlace | 5/17/2013
-
InvestorPlace | 4/26/2013
-
Seeking Alpha | 4/22/2013
-
InvestorPlace | 4/22/2013
-
Seeking Alpha | 4/13/2013
-
Seeking Alpha | 4/11/2013
-
InvestorPlace | 3/19/2013
| Symbol | Value ($) |
|---|---|
| Category | Specialty - Health |
| Morningstar Risk | High |
| Morningstar Rating | |
| Morningstar Return | Above Average |
| Symbol | Value ($) |
|---|---|
| Stocks | 99.94% |
| Cash | 0.06% |
| Fixed Income | 0.00% |
| Other | 0.00% |
| NAME | % NET ASSETS |
|---|---|
| NPS Pharmaceuticals Inc | 3.55% |
| Vertex Pharmaceuticals | 3.16% |
| Theravance, Inc. | 2.96% |
| Alkermes PLC | 2.91% |
| Biogen Idec Inc | 2.76% |
| Isis Pharmaceuticals | 2.75% |
| Regeneron Pharmaceuticals, Inc. | 2.70% |
| Seattle Genetics, Inc. | 2.59% |
| Acorda Therapeutics, Inc. | 2.52% |
| Aegerion Pharmaceuticals, Inc. | 2.47% |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Quotes delayed 15min, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
